ORASURE TECHNOLOGIES INC OSUR
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1986-11-17
ORASURE TECHNOLOGIES INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $115.0M | $185.8M | $405.5M | $387.5M | $233.7M |
| Gross profit | $48.2M | $79.4M | $171.7M | $148.4M | $117.6M |
| R&D expense | $42.5M | $26.0M | $33.7M | $36.2M | $34.2M |
| Operating income | -$72.0M | -$28.2M | $32.7M | -$22.2M | -$10.2M |
| Income tax | $1.8M | $1.8M | $2.6M | $1.5M | $13.7M |
| Net income | -$68.7M | -$19.5M | $53.7M | -$17.1M | -$23.0M |
| EPS (diluted) | $-0.94 | $-0.26 | $0.72 | $-0.24 | $-0.32 |
| Operating cash flow | -$49.0M | $27.4M | $141.6M | -$47.2M | -$35.4M |
| Free cash flow | -$53.2M | $23.6M | $135.8M | -$54.0M | -$57.3M |
| Cash & equivalents | $199.3M | $267.8M | $290.4M | $84.0M | $116.8M |
| Inventory | $31.1M | $34.2M | $47.6M | $95.7M | $53.1M |
| Total assets | $403.2M | $479.7M | $482.8M | $444.2M | $461.0M |
| Total liabilities | $62.3M | $69.3M | $52.2M | $79.8M | $80.5M |
| Shareholders' equity | $340.8M | $410.3M | $430.7M | $364.4M | $380.5M |
Source: SEC EDGAR filings · CIK 0001116463 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.